BioCardia, Inc. Common Stock (BCDA)
BioCardia, Inc. (BCDA) is a biotechnology company focused on developing therapies for cardiovascular disease. It specializes in innovative cell delivery systems and regenerative treatments aimed at improving outcomes for patients with heart-related conditions.
Company News
BioCardia's CEO Peter Altman will present a corporate update at the H. C. Wainwright conference, discussing clinical cell therapy programs, regulatory activities, and recent partnerships in cardiovascular therapeutics.
U.S. stocks traded lower toward the end of trading, with the S&P 500 edging lower on Monday. The Dow traded down 0.20% to 39,007.30 while the NASDAQ fell 0.18% to 16,245.77. The S&P 500 also fell, dropping, 0.01% to 5,137.05. Check This Out: Top 4 Tech Stocks That May Implode This Month  Leading and Lagging Sectors  Utilities shares rose by ...
The FDA approves BioCardia's (BCDA) phase III study on its CardiAMP cell therapy to treat patients with ischemic heart failure.
Here's what you need to know about buying penny stocks on April 12th The post Top Penny Stocks to Buy? 3 As Stock Futures Climb Before Market Open appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.